220 related articles for article (PubMed ID: 18299450)
1. DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.
Rosinski KV; Fujii N; Mito JK; Koo KK; Xuereb SM; Sala-Torra O; Gibbs JS; Radich JP; Akatsuka Y; Van den Eynde BJ; Riddell SR; Warren EH
Blood; 2008 May; 111(9):4817-26. PubMed ID: 18299450
[TBL] [Abstract][Full Text] [Related]
2. Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro.
Laurin D; Spierings E; van der Veken LT; Hamrouni A; Falkenburg JH; Souillet G; Vermeulen C; Farre A; Galambrun C; Rigal D; Bertrand Y; Goulmy E; Eljaafari A
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1114-24. PubMed ID: 17085304
[TBL] [Abstract][Full Text] [Related]
3. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.
Vogt MH; Goulmy E; Kloosterboer FM; Blokland E; de Paus RA; Willemze R; Falkenburg JH
Blood; 2000 Nov; 96(9):3126-32. PubMed ID: 11049993
[TBL] [Abstract][Full Text] [Related]
4. Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.
Hirosawa T; Torikai H; Yanagisawa M; Kamei M; Imahashi N; Demachi-Okamura A; Tanimoto M; Shiraishi K; Ito M; Miyamura K; Shibata K; Kikkawa F; Morishima Y; Takahashi T; Emi N; Kuzushima K; Akatsuka Y
Cancer Sci; 2011 Jul; 102(7):1281-6. PubMed ID: 21466613
[TBL] [Abstract][Full Text] [Related]
5. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
Vogt MH; van den Muijsenberg JW; Goulmy E; Spierings E; Kluck P; Kester MG; van Soest RA; Drijfhout JW; Willemze R; Falkenburg JH
Blood; 2002 Apr; 99(8):3027-32. PubMed ID: 11929796
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
Warren EH; Greenberg PD; Riddell SR
Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells.
Bonnet D; Warren EH; Greenberg PD; Dick JE; Riddell SR
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8639-44. PubMed ID: 10411928
[TBL] [Abstract][Full Text] [Related]
8. Minor histocompatibility antigens--targets of graft versus leukemia responses.
Riddell SR; Murata M; Bryant S; Warren EH
Int J Hematol; 2002 Aug; 76 Suppl 2():155-61. PubMed ID: 12430918
[TBL] [Abstract][Full Text] [Related]
9. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.
Nakamura R; La Rosa C; Tsai W; Lacey SF; Srivastava T; Seidel A; Senitzer D; Forman SJ; Diamond DJ
Transpl Immunol; 2014 May; 30(4):128-35. PubMed ID: 24582729
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation.
Spierings E; Vermeulen CJ; Vogt MH; Doerner LE; Falkenburg JH; Mutis T; Goulmy E
Lancet; 2003 Aug; 362(9384):610-5. PubMed ID: 12944060
[TBL] [Abstract][Full Text] [Related]
12. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
13. Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells.
Norde WJ; Overes IM; Maas F; Fredrix H; Vos JC; Kester MG; van der Voort R; Jedema I; Falkenburg JH; Schattenberg AV; de Witte TM; Dolstra H
Blood; 2009 Mar; 113(10):2312-23. PubMed ID: 19074734
[TBL] [Abstract][Full Text] [Related]
14. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
Tykodi SS; Fujii N; Vigneron N; Lu SM; Mito JK; Miranda MX; Chou J; Voong LN; Thompson JA; Sandmaier BM; Cresswell P; Van den Eynde B; Riddell SR; Warren EH
Clin Cancer Res; 2008 Aug; 14(16):5260-9. PubMed ID: 18698046
[TBL] [Abstract][Full Text] [Related]
15. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.
Bleakley M; Otterud BE; Richardt JL; Mollerup AD; Hudecek M; Nishida T; Chaney CN; Warren EH; Leppert MF; Riddell SR
Blood; 2010 Jun; 115(23):4923-33. PubMed ID: 20203263
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
[TBL] [Abstract][Full Text] [Related]
17. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
[TBL] [Abstract][Full Text] [Related]
18. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.
Faber LM; van Luxemburg-Heijs SA; Veenhof WF; Willemze R; Falkenburg JH
Blood; 1995 Oct; 86(7):2821-8. PubMed ID: 7670118
[TBL] [Abstract][Full Text] [Related]
19. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
Warren EH; Fujii N; Akatsuka Y; Chaney CN; Mito JK; Loeb KR; Gooley TA; Brown ML; Koo KK; Rosinski KV; Ogawa S; Matsubara A; Appelbaum FR; Riddell SR
Blood; 2010 May; 115(19):3869-78. PubMed ID: 20071660
[TBL] [Abstract][Full Text] [Related]
20. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation.
Rufer N; Wolpert E; Helg C; Tiercy JM; Gratwohl A; Chapuis B; Jeannet M; Goulmy E; Roosnek E
Transplantation; 1998 Oct; 66(7):910-6. PubMed ID: 9798702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
